Archive

Medical Category: Hematology and Oncology

Classic Journal Club: TXA for Epistaxis

Background: Epistaxis is a common ailment experienced by millions worldwide. While most of these cases can be managed by patients at home, some will require medical attention. Initial interventions include local pressure, ice, and forward head positioning for persistent bleeds. When …

Read More
Head, Eye, Ear, Nose, and ThroatHematology and Oncology

REBEL Core Cast – Basics of EM – Mega Summary – Part 2

Take Home Points Emergency medicine revolves around the differential diagnosis History and physical exam should significantly narrow your differential diagnosis Have an idea of what specific diagnoses are being ruled out when ordering diagnostic tests Always consider the most life-threatening and …

Read More
Abdominal and GastroinstestinalCardiovascularDermatologyEndocrine, Metabolic, Fluid, and ElectrolytesHematology and OncologyInfectious DiseaseNeurologyObstetrics and GynecologyOrthopedicsResuscitationTrauma

REBEL Core Cast – Basics of EM – Introduction

REBEL Core Cast – Basics of Emergency Medicine Podcast Welcome to the EMRA Basics of Emergency Medicine Podcast. I am your host EJ Wright, and the following series is an all encompassing approach to the most common chief complaints in …

Read More
Abdominal and GastroinstestinalAllergy and ImmunologyCardiovascularDermatologyEndocrine, Metabolic, Fluid, and ElectrolytesEnvironmentalHead, Eye, Ear, Nose, and ThroatHematology and OncologyInfectious DiseaseNeurologyObstetrics and GynecologyOrthopedicsRenal and GenitourinaryResuscitationThoracic and RespiratoryToxicologyTrauma

REBEL Cast Ep109: The RePHILL Trial

Background: Currently, trauma resuscitation focuses on immediate hemorrhage control, resuscitation with blood products (i.e. PRBCs, plasma) and early administration of tranexamic acid.  The evidence for the use of blood-based resuscitation in the pre-hospital system has been mixed (PAMPer and COMBAT …

Read More
Hematology and OncologyTrauma

The INSPIRATION Trial: Intermediate Dose Anticoagulation in Critically Ill Patients with COVID-19

Background: COVID-19 infection increases the risk of thrombosis due to multiple factors.(Rico-Mesa, 2020). Over the last 2 years, researchers have published 12 RCTs investigating various anticoagulation strategies among patients diagnosed with COVID-19 in multiple clinical settings. To date, only a multiplatform …

Read More
CardiovascularHematology and OncologyInfectious DiseaseThoracic and Respiratory

Sponsored

0